Mr Marc Moore

  1. 2018
  2. Published

    Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy

    Benedetti, S., Uno, N., Hoshiya, H., Ragazzi, M., Ferrari, G., Kazuki, Y., Moyle, L. A., Tonlorenzi, R., Lombardo, A., Chaouch, S., Mouly, V., Moore, M., Popplewell, L., Kazuki, K., Katoh, M., Naldini, L., Dickson, G., Messina, G., Oshimura, M., Cossu, G. & 1 others, Tedesco, F. S., 1 Feb 2018, In : EMBO Reports. 10, 2, p. 254-275 22 p.

    Research output: Contribution to journalArticle

  3. Unpublished
  4. 2016
  5. Published

    Current Progress in Therapeutic Gene Editing for Monogenic Diseases

    Prakash, V., Moore, M. & Yáñez-Muñoz, R. J., Mar 2016, In : Molecular Therapy. 24, 3, p. 465-474 10 p.

    Research output: Contribution to journalArticle

  6. Published

    piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts

    Loperfido, M., Jarmin, S., Dastidar, S., Di Matteo, M., Perini, I., Moore, M., Nair, N., Samara-Kuko, E., Athanasopoulos, T., Tedesco, F. S., Dickson, G., Sampaolesi, M., VandenDriessche, T. & Chuah, M. K., 29 Jan 2016, In : Nucleic Acids Research. 44, 2, p. 744-760 17 p.

    Research output: Contribution to journalArticle